Preoperative Maximum Oxygen Consumption Is associated with Prognosis After Pulmonary Resection in Stage I Non-small Cell Lung Cancer
Overview
Pulmonary Medicine
Authors
Affiliations
Background: The objective of this investigation was to evaluate whether maximum oxygen consumption (VO2max) is a reliable prognostic factor after lung resection for pathologic stage I non-small cell lung cancer (NSCLC).
Methods: Observational analysis of 157 patients undergoing pulmonary lobectomy or segmentectomy for pathologic stage I (T1 or T2-N0 only) NSCLC, with preoperative measurement of Vo2max and complete follow-up (2006-2011). Survival was calculated by the Kaplan-Meier method. The log-rank test was used to assess differences in survival between groups. The relationships between survival and several baseline and clinical variables were determined by Cox multivariate analyses.
Results: The median follow-up time was 40 months. The average preoperative Vo2max was 16.1 mL/kg · min and 69% of predicted value. Sixty-two (40%) patients had a Vo2max below 60%. The median and 5-year overall survivals of patients with preoperative Vo2max above 60% were significantly longer than in those with Vo2max below 60% (median not reached vs 48 months: 73% vs 40%, p=0.0004). Cox regression model showed that an age older than 70 years (p=0.005, hazard ratio 2.3) and Vo2max below 60% (p=0.001, hazard ratio 2.4) were independent prognostic factors significantly associated with overall survival. Cancer-specific survival was also longer in patients with Vo2max above 60% (81% vs 61%, p=0.01).
Conclusions: Exercise tolerance may influence the physiologic outcomes associated with cancer that can potentially affect survival. Physical rehabilitation aimed at improving exercise tolerance can possibly improve the long-term prognosis after operations for lung cancer.
Dun Y, Cui N, Wu S, Fu S, Ripley-Gonzalez J, Zhou N Ann Med. 2023; 55(2):2295981.
PMID: 38128485 PMC: 10763904. DOI: 10.1080/07853890.2023.2295981.
Nawoor-Quinn Z, Oliver A, Raobaikady R, Mohammad K, Cone S, Kasivisvanathan R Perioper Med (Lond). 2022; 11(1):48.
PMID: 36138428 PMC: 9494857. DOI: 10.1186/s13741-022-00279-8.
Validity of Estimated Cardiorespiratory Fitness in Patients With Primary Breast Cancer.
Michalski M, Rowed K, Lavery J, Moskowitz C, Capaci C, Stene G JACC CardioOncol. 2022; 4(2):210-219.
PMID: 35818548 PMC: 9270626. DOI: 10.1016/j.jaccao.2022.05.003.
Scott J, Thomas S, Herndon 2nd J, Douglas P, Yu A, Rusch V J Cachexia Sarcopenia Muscle. 2021; 12(6):1456-1465.
PMID: 34658160 PMC: 8718021. DOI: 10.1002/jcsm.12828.
Li J, Qiu Y, Yi J, Liu X, Zhang S, Tan D J Oncol. 2021; 2021:8820691.
PMID: 34603450 PMC: 8486509. DOI: 10.1155/2021/8820691.